ARCHIVES

New Technology May Enable Therapy Tailored To Patient’s Predicted Response

This article is from The Cancer Letter archive.

Vol. 25 No. 4 | April 26, 2002

Download PDF Visit The Full Archive

Related Articles

House report offers encouragement, but little else, for NCI’s 2015 plan, endorses “biobank” and caBIG.

July 1, 2005

FDA Rile Changes Reporting Requirements for Adverse Events

November 18, 1994

Letter to the Editors: Researchers Must Keep Up NIH Advocacy Particularly Now

October 11, 1996

NCI TO Issue RFA For Gene Therapy Studies; $20 Mil. Se-Aside Ok’d

January 10, 1992

BioSeek Awarded NIH SBIR For Compound Validation.

July 4, 2003

In Brief: Schmidt Advises Upton To Consider Moving Control Projects In Other Division To DCCR

December 2, 1977